2017
DOI: 10.1016/j.ejmech.2016.10.041
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
34
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 77 publications
(35 citation statements)
references
References 38 publications
1
34
0
Order By: Relevance
“…Currently, the development of metal complexes with nonplatinum central atoms including ruthenium [11], gold [12], silver [13], copper [14], zinc [15], Manganese [16], nickel [17], iridium [18] and cobalt [19] has been one of the hottest emerging areas of anticancer drug research. Among these, carbonyl cobalt complex has strong properties of cancer prevention including tumour growth/metastasis suppression [20], antiproliferative [21], DNA cleavage [22], apoptotic induction [23] and autophagy [8], which was more active than cisplatin on the human breast tumour cell lines (MCF-7 and MDA-MB-231) [24,25] and ovarian cancer cells (SKOV3/ DDP) [26].…”
Section: Introductionmentioning
confidence: 99%
“…Currently, the development of metal complexes with nonplatinum central atoms including ruthenium [11], gold [12], silver [13], copper [14], zinc [15], Manganese [16], nickel [17], iridium [18] and cobalt [19] has been one of the hottest emerging areas of anticancer drug research. Among these, carbonyl cobalt complex has strong properties of cancer prevention including tumour growth/metastasis suppression [20], antiproliferative [21], DNA cleavage [22], apoptotic induction [23] and autophagy [8], which was more active than cisplatin on the human breast tumour cell lines (MCF-7 and MDA-MB-231) [24,25] and ovarian cancer cells (SKOV3/ DDP) [26].…”
Section: Introductionmentioning
confidence: 99%
“…In addition to the expected biological properties of the Schiff base compounds, [30][31][32][33][34][35] binding the cobalt, copper and zinc atoms to this unit make these complexes a good prospect for biologically active compounds [36][37][38][39][40][41][42][43][44][45][46][47][48][49][50] (31)(32)(33)(34)(35) for zinc, 36-40 for cobalt, 41-45 for copper). For the study of the biological activities of new ligand (H 3 L Br ) and its complexes 1-3, docking calculations were run to investigate the possibility of interaction between these compounds with nine protein targets, including: BRAF kinase, cathepsin B (CatB), DNA gyrase, histone deacetylase (HDAC7), recombinant human albumin (rHA), ribonucleotide reductases (RNR), thioredoxin reductase (TrxR), thymidylate synthase (TS), topoisomerase II (Top II).…”
Section: Introductionmentioning
confidence: 99%
“…Xu et al [28] reported the synthesis of compounds 6a, 6b using zinc iodide catalyzed conditions, Lacerda et al [29] synthesized compound 6c, 7a using AcOH catalyzed reaction condition, Shinde et al [31] reported the synthesis of compound 6d using LaCl3·7H2O. Kiselyov [32] reported the synthesis of compound 6e using N-fluoropyridinium salts, Dam et al [33] reported the synthesis of 7d using Montmorillonite K-10 clay as catalyst. To the best of our knowledge, the synthesis of compounds 6f, 7b, 7c, 7e-7f are new and have not been reported in the literature so far.…”
Section: Resultsmentioning
confidence: 99%